1-9 of 9
Yolaine Jeune-Smith
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Provider Perceptions of Shine and Ibrutinib, Bendamustine, and Rituximab in the First-Line Setting

Samuel C. Baird, Robert N. Bone, Yolaine Jeune-Smith, Bruce A. Feinberg, Muhamed Baljevic
Journal: Blood
Blood (2022) 140 (Supplement 1): 13234–13235.
https://doi.org/10.1182/blood-2022-166976
Published: 2022
Journal Articles

The Determination Trial Impact on Upfront (vs Delayed) Autologous Stem Cell Transplantation for Transplant-Eligible Newly Diagnosed Multiple Myeloma

Brooke Dulka, Robert N. Bone, Yolaine Jeune-Smith, Muhamed Baljevic, Bruce A. Feinberg
Journal: Blood
Blood (2022) 140 (Supplement 1): 10958–10959.
https://doi.org/10.1182/blood-2022-166490
Published: 2022
Journal Articles

Barriers to Referral for Chimeric Antigen Receptor T Cell (CAR-T) Therapies Among U.S. Community Hematologists/Oncologists (cH/O)

Ajeet Gajra, Yolaine Jeune-Smith, Bruce A. Feinberg
Journal: Blood
Blood (2021) 138 (Supplement 1): 4010.
https://doi.org/10.1182/blood-2021-151789
Published: 2021
Journal Articles

U.S-Based Community Oncologists/Hematologists' Perceptions Regarding Future Use of Gene Therapies for Patients with Hematological Disorders

Ajeet Gajra, Stephanie Fortier, Yolaine Jeune-Smith, Bruce A. Feinberg
Journal: Blood
Blood (2021) 138 (Supplement 1): 2986.
https://doi.org/10.1182/blood-2021-148165
Published: 2021
Journal Articles

Assessment of Measurable Residual Disease (MRD) in Chronic Lymphocytic Leukemia (CLL) and Multiple Myeloma (MM) Among U.S. Community Hematologists/ Oncologists (cH/O)

Ajeet Gajra, MD MBBS, Yamini S Rathish, Yolaine Jeune-Smith, PhD, Andrew J Klink, PhD MPH, Bruce Feinberg, DO
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
https://doi.org/10.1182/blood-2020-142005
Published: 2020
Journal Articles

Adoption of Approved CAR-T Therapies Among US Community Hematologists/ Oncologists

Ajeet Gajra, MD MBBS, Skyler Hime, Yolaine Jeune-Smith, PhD, Bruce Feinberg, DO
Journal: Blood
Blood (2020) 136 (Supplement 1): 34–35.
https://doi.org/10.1182/blood-2020-141990
Published: 2020
Journal Articles

Perceptions of Community Hematologists/Oncologists on Barriers to Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Diffuse Large B-Cell Lymphoma

Ajeet Gajra, MD FACP, Richard Sweat, PhD, Yolaine Jeune-Smith, PhD, Jonathan K. Kish, PhD MPH, Bruce A Feinberg, DO
Journal: Blood
Blood (2019) 134 (Supplement_1): 2198.
https://doi.org/10.1182/blood-2019-127741
Published: 2019
Journal Articles

Perceptions of Community Hematologists/Oncologists on the Potential of Data Presented at ASH 2018 and ASCO 2019 to Alter the Standard of Care for Multiple Myeloma Treatment

Ajeet Gajra, MD FACP, Richard Sweat, PhD, Yolaine Jeune-Smith, PhD, Bruce Feinberg, DO
Journal: Blood
Blood (2019) 134 (Supplement_1): 5822.
https://doi.org/10.1182/blood-2019-129502
Published: 2019
Journal Articles

Potential of 2018 ASH CLL Data to Alter Standard of Care for Initial CLL Treatment

Bruce A Feinberg, DO, Richard Sweat, PhD, Yolaine Jeune-Smith, PhD, Ajeet Gajra, MD FACP
Journal: Blood
Blood (2019) 134 (Supplement_1): 5816.
https://doi.org/10.1182/blood-2019-129029
Published: 2019